Acerca de
Nuestra Labor
Datos y herramientas
Eventos
Noticias
news-year-end-dec2022

¡Feliz año nuevo le desea la Federación Mundial de Hemofilia!

2022 fue un año maravilloso para las personas con trastornos de la coagulación alrededor del mundo. A pesar de los constantes desafíos relacionados con la pandemia de COVID-19, todos continuamos trabajando con miras al logro de nuestra visión de Tratamiento para todos.

También disponible en: English Français

Deseamos celebrar a nuestros voluntarios, a los miembros de los consejos directivos de la FMH y de la FMH USA, a las organizaciones nacionales miembros (ONM), a profesionales de la salud, personal y miembros de la comunidad de todo el mundo por su inquebrantable dedicación. Sin ustedes, no habríamos podido apoyar a la comunidad de trastornos de la coagulación de la manera en la que lo hicimos. Sin ustedes, eventos como el Congreso Mundial 2022 de la FMH, el Día mundial de la hemofilia, la Cumbre mundial 2022 sobre políticas y acceso a tratamiento (GPAS por su sigla en inglés), y la Mesa redonda de la FMH sobre terapia génica no habrían sido posibles.

Estamos emocionados por las nuevas oportunidades que traerá consigo el 2023 ¡y esperamos poder saludar personalmente a los participantes del mundo entero que nos acompañaran en Buenos Aires durante la Cumbre 2023 de la FMH sobre atención integral!

Para ver nuestro video de Año Nuevo haga clic aquí.

A nombre de la FMH, ¡feliz año nuevo!

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.